Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer
Abstract Pre-clinical and retrospective studies of patients using statins to reduce plasma cholesterol have suggested that statins may be useful to treat cancer. However, prospective clinical trials have yet to demonstrate significant efficacy. We have previously shown that this is in part because a...
Guardado en:
Autores principales: | Elizabeth de Wolf, Marwan Ibrahim Abdullah, Stefanie M. Jones, Karen Menezes, Darren M. Moss, Falko P. Drijfhout, Sarah R. Hart, Clare Hoskins, Euan A. Stronach, Alan Richardson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba16009471344089ac5a439986164551 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells
por: Marwan Ibrahim Abdullah, et al.
Publicado: (2017) -
Statins and diabetes: focus on pitavastatin
por: Soreiia A. Urazgildeeva
Publicado: (2020) -
Pitavastatin: focus on safety and drug interactions
por: Larisa O. Minushkina, et al.
Publicado: (2021) -
Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients
por: Chamberlin KW, et al.
Publicado: (2015) -
Anti-asthmatic effect of pitavastatin through aerosol inhalation is associated with CD4+ CD25+ Foxp3+ T cells in an asthma mouse model
por: Songquan Wu, et al.
Publicado: (2017)